Enrique de Álava
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment 91
- Rheumatology top 0.5%
- Bone Tumor Diagnosis and Treatments 13
- Oncology top 1%
- Vascular Tumors and Angiosarcomas 12
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 18
-
- Lymphoma Diagnosis and Treatment 19
-
- Cardiac tumors and thrombi 22
-
- Gastrointestinal Tumor Research and Treatment 13
-
- Neuroblastoma Research and Treatments 10
Enrique de Álava
178 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Pulmonary and Respiratory Medicine 3.8k
- Rheumatology 1.2k
- Oncology 1.9k
- Cancer Research 953
- Pathology and Forensic Medicine 1.0k
Countries citing papers authored by Enrique de Álava
This map shows the geographic impact of Enrique de Álava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique de Álava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique de Álava more than expected).
Fields of papers citing papers by Enrique de Álava
This network shows the impact of papers produced by Enrique de Álava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique de Álava. The network helps show where Enrique de Álava may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Enrique de Álava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 26 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 19 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 6 | |
| 14 | 2020 | 23 | |
| 15 | 2020 | 7 | |
| 16 | 2019 | 21 | |
| 17 | 2017 | 4 | |
| 18 | 2015 | 36 | |
| 19 | 2011 | 10 | |
| 20 | 2008 | 57 |
About Enrique de Álava
Enrique de Álava is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Cancer Research, having authored 186 papers that have together received 6.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (91 papers), Cardiac tumors and thrombi (22 papers), Lymphoma Diagnosis and Treatment (19 papers), Cancer Genomics and Diagnostics (18 papers), Gastrointestinal Tumor Research and Treatment (13 papers), Bone Tumor Diagnosis and Treatments (13 papers), Vascular Tumors and Angiosarcomas (12 papers) and Neuroblastoma Research and Treatments (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.8k citations), Rheumatology (1.2k citations) and Oncology (1.9k citations). Enrique de Álava has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include William L. Gerald, Marc Ladanyi, Juan Rosaí, José Luis Ordóñez, Teresa Hernández, Heinrich Kovar, Uta Dirksen, Thomas G. P. Grünewald, Daniel Osuna and Olivier Delattre. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.